Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction - Wikidata - wikimedia - TriplyDB

Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction

Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction

http://www.wikidata.org/entity/Q28484387

about

DNA repair targeted therapy: The past or future of cancer treatment?Anti-HBV Drugs: Progress, Unmet Needs, and New Hope dMM-PBSA: A New HADDOCK Scoring Function for Protein-Peptide Docking Applications of computer-aided approaches in the development of hepatitis C antiviral agents.Targeting DNA repair pathways for cancer treatment: what's new?Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV Interface.Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck.Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.DNA Repair Endonucleases: Physiological Roles and Potential as Drug Targets.Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1.An in silico protocol for identifying mTOR inhibitors from natural products.Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma.Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine.Nucleotide Excision Repair: From Neurodegeneration to Cancer.Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease.DNA repair pathways and cisplatin resistance: an intimate relationship Exploring the biological consequences of conformational changes in aspartame models containing constrained analogues of phenylalanine

P2860

Q26768679-B99F46EC-0232-4D12-9EFB-5115E944A142 Q26782742-2D842D1E-3C1D-40EF-9DBA-600F181987FE Q28596516-640B56D2-919F-434C-9C12-9579D7AB46AB Q30238530-EB409153-EE6F-4473-B0CD-5444102A68DD Q34015040-FF4F6616-6DC3-4433-BE02-CF6F5912154D Q35223337-8BB3361E-59FC-4193-8EAD-FB1E033EF197 Q36557333-6EA2BAD0-3BA2-448D-89C6-067C69B6782C Q36674946-37CA109F-4920-4097-8DF2-A0F978DB0BEE Q37328494-432D363B-D876-4328-839C-FC6F86119A54 Q37688903-92012EB8-3824-4537-8C41-86ACF3A79AAA Q38422476-C4E7E3B3-52B3-4353-8CE4-D65541B79EE5 Q41549007-C580D83F-7890-42F8-B29A-8C0613D1078B Q42197995-AF33D00A-6F8A-40F3-93C7-B69F26F58FCD Q42541262-90B5DB8E-B42C-431B-A68F-604C45209BB1 Q49473342-A5775D4D-196C-4D48-B6FE-C3C8CE46110C Q50428930-9411C871-E6D4-47B5-8816-77CC885611BC Q52715489-57786C9A-9155-451D-822D-F386678E6D7B Q58699219-B604D9D6-5469-429C-A797-8F02EA4D4716 Q58855637-66130BBF-547F-43A1-BAB4-CE6EC979EC6B

P2860

Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction

http://www.wikidata.org/entity/Q28484387

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@ast

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@en

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@nl

type

label

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@ast

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@en

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@nl

prefLabel

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@ast

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@en

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@nl

P1433

Q28484387-B118AD62-22D7-46D2-8E29-599886E147D2

P1476

Q28484387-7D707185-64C9-4F08-B760-CC550BAE0815

P2093

Q28484387-1286758C-A638-437A-8D88-B2A657977836

Q28484387-163FC327-9182-4222-B1ED-4932EA5FD093

Q28484387-2F46D2A9-87F7-4907-9214-FDDF349F5066

Q28484387-3F79ABCF-1F4B-452D-B599-954DAE54A6B5

Q28484387-DFEA5D91-3065-4191-8145-429D73495D89

P2860

Q28484387-05331BC1-F4CD-43C3-80EA-AC94477C4281

Q28484387-10A9A788-B119-48A1-89A4-029B0000E101

Q28484387-1C1F0A1D-2689-4BA2-AE31-C4D32BF9644C

Q28484387-22508AF0-317D-421E-B214-1E5BE3989215

Q28484387-22C5FE24-13F2-4B5C-9120-21711655965A

Q28484387-25D82855-B459-4E6C-A364-8FFAF9D91A5D

Q28484387-2956C93C-3398-4BD3-907A-6F1E999E2E5C

Q28484387-38B277EA-CF45-4518-BDB6-1BA66EF2CF04

Q28484387-39013774-CB61-4AD5-83DF-DC2C592C145B

Q28484387-3B773095-6D52-464C-B83B-7DCDB17125BB

P304

Q28484387-D5FDFB96-C87E-45E8-8A09-1C3BD61971E8

P31

Q28484387-8DA922DD-8302-4F2E-B141-1BBCFC25A93F

P3181

Q28484387-5D4BEB59-4901-4D3D-B94D-630DC9B62F73

P356

Q28484387-65B2A16C-A1A2-438F-949D-D6B286F8F89D

P407

Q28484387-5BF6BE21-ADC6-4D97-AA34-2A1C6FB5886D

P433

Q28484387-F2498E61-4CE8-4239-A702-BC829AFE918C

P478

Q28484387-2B753269-8DF3-4751-B915-5FBAE9FA9CF1

P50

Q28484387-E2F6DA03-9D32-4E29-BC61-FF2960F2BB5B

P577

Q28484387-83932FC7-6558-45D6-A3A6-48CF1E039029

P5875

Q28484387-46D6990B-4947-43E4-A296-D8D991D86516

P698

Q28484387-74334A12-E482-4A69-BE71-D4D3822C4E1A

P932

Q28484387-7507A4C4-E0AD-4B86-B98D-1267212DCAD1

P3181

P356

JOURNAL.PONE.0051329

P1433

P1476

Virtual screening and biologic ...... ting the XPA-ERCC1 interaction

@en

P2093

Charles Dumontet

http://www.w3.org/2001/XMLSchema#string

Jack A Tuszynski

http://www.w3.org/2001/XMLSchema#string

Khaled H Barakat

http://www.w3.org/2001/XMLSchema#string

Lars P Jordheim

http://www.w3.org/2001/XMLSchema#string

Rolando Perez-Pineiro

http://www.w3.org/2001/XMLSchema#string

P2860

XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair

Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA

The Amber biomolecular simulation programs

Comparison of multiple Amber force fields and development of improved protein backbone parameters

Structure-based discovery of inhibitors of thymidylate synthase

Development and testing of a general amber force field

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models

PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations

Virtual screening and fast automated docking methods.

P304

e51329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3785104

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0051329

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

David S Wishart

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234000248

http://www.w3.org/2001/XMLSchema#string

P698

23272099

http://www.w3.org/2001/XMLSchema#string

P932

3522735

http://www.w3.org/2001/XMLSchema#string